Patents Assigned to InfoRLife SA
  • READY-TO-USE SODIUM BICARBONATE FORMULATIONS AND PRODUCTS
    Publication number: 20260158059
    Abstract: The invention includes a sodium bicarbonate product that is sterile and ready-to-use and can be stored at room temperature for a period of six months or more, including an aqueous sodium bicarbonate solution at a concentration suitable for administration to a patient, which does not contain a preservative or antimicrobial, in an infusion container. The invention includes methods of making and using the sodium bicarbonate product.
    Type: Application
    Filed: December 5, 2024
    Publication date: June 11, 2026
    Applicant: INFORLIFE SA
    Inventors: Sergio Dusci, Abramo Civera
  • READY-TO-USE PHENYLEPHRINE FORMULATIONS AND PRODUCTS
    Publication number: 20250325479
    Abstract: The invention includes a phenylephrine product including an aqueous phenylephrine solution, a tonicity adjusting agent, at least one pH adjusting agent, at least one buffering agent and water for injection, wherein the phenylephrine solution is does not comprise sodium metabisulfite, wherein the phenylephrine product is sterile and ready-to-use and contain an oxygen absorber to keep the oxygen dissolved below 1 ppm. The invention includes methods of making and using the phenylephrine product.
    Type: Application
    Filed: July 3, 2025
    Publication date: October 23, 2025
    Applicant: INFORLIFE SA
    Inventor: Sergio DUSCI
  • READY-TO-USE KETAMINE PREMIX FORMULATION
    Publication number: 20250312294
    Abstract: The invention relates to a sterile, ready-to-use, stable aqueous solution of ketamine suitable for direct intravenous infusion to a patient in need thereof, wherein the composition is disposed within a sealed infusion container as a premixture. The invention further relates to aqueous solutions of ketamine that are free of antimicrobials such as benzethonium chloride and are shelf-stable. The pharmaceutical compositions can be used, for example, wherein the subject is in need of anesthesia for a diagnostic or a surgical procedure.
    Type: Application
    Filed: June 23, 2025
    Publication date: October 9, 2025
    Applicant: INFORLIFE SA
    Inventor: Sergio DUSCI
  • Ready-to-use phenylephrine formulations and products
    Patent number: 12383497
    Abstract: The invention includes a phenylephrine product including an aqueous phenylephrine solution, a tonicity adjusting agent, at least one pH adjusting agent, at least one buffering agent and water for injection, wherein the phenylephrine solution is does not comprise sodium metabisulfite, wherein the phenylephrine product is sterile and ready-to-use and contain an oxygen absorber to keep the oxygen dissolved below 1 ppm. The invention includes methods of making and using the phenylephrine product.
    Type: Grant
    Filed: July 17, 2024
    Date of Patent: August 12, 2025
    Assignee: INFORLIFE SA
    Inventor: Sergio Dusci
  • Ready-to-use ketamine premix formulation
    Patent number: 12370153
    Abstract: The invention relates to a sterile, ready-to-use, stable aqueous solution of ketamine suitable for direct intravenous infusion to a patient in need thereof, wherein the composition is disposed within a sealed infusion container as a premixture. The invention further relates to aqueous solutions of ketamine that are free of antimicrobials such as benzethonium chloride and are shelf-stable. The pharmaceutical compositions can be used, for example, wherein the subject is in need of anesthesia for a diagnostic or a surgical procedure.
    Type: Grant
    Filed: July 11, 2024
    Date of Patent: July 29, 2025
    Assignee: INFORLIFE SA
    Inventor: Sergio Dusci
  • READY-TO-USE PHENYLEPHRINE FORMULATIONS AND PRODUCTS
    Publication number: 20250099381
    Abstract: The invention includes a phenylephrine product including an aqueous phenylephrine solution, a tonicity adjusting agent, at least one pH adjusting agent, at least one buffering agent and water for injection, wherein the phenylephrine solution is does not comprise sodium metabisulfite, wherein the phenylephrine product is sterile and ready-to-use and contain an oxygen absorber to keep the oxygen dissolved below 1 ppm. The invention includes methods of making and using the phenylephrine product.
    Type: Application
    Filed: July 17, 2024
    Publication date: March 27, 2025
    Applicant: INFORLIFE SA
    Inventor: Sergio DUSCI
  • READY-TO-USE KETAMINE PREMIX FORMULATION
    Publication number: 20250025431
    Abstract: The invention relates to a sterile, ready-to-use, stable aqueous solution of ketamine suitable for direct intravenous infusion to a patient in need thereof, wherein the composition is disposed within a sealed infusion container as a premixture. The invention further relates to aqueous solutions of ketamine that are free of antimicrobials such as benzethonium chloride and are shelf-stable. The pharmaceutical compositions can be used, for example, wherein the subject is in need of anesthesia for a diagnostic or a surgical procedure.
    Type: Application
    Filed: July 11, 2024
    Publication date: January 23, 2025
    Applicant: INFORLIFE SA
    Inventor: Sergio DUSCI
  • Midazolam in flexible bags
    Patent number: 10966990
    Abstract: Terminally sterilized, preservative-free aqueous midazolam solution comprising 0.25 to 1.5 mg/ml of midazolam, a tonicity adjusting agent to provide an osmolality of from 260 and 320 mosm/kg and sufficient acid and optionally a base to provide a pH of from about 2.5 to 3.5 with the remainder water for injection packaged in a flexible plastic container.
    Type: Grant
    Filed: June 20, 2018
    Date of Patent: April 6, 2021
    Assignee: InfoRLife SA
    Inventor: Sergio Dusci
  • Storage stable ready-to-use norepinephrine aqueous solutions in flexible plastic bags
    Patent number: 10888534
    Abstract: A sterile, sulfite-free aqueous norepinephrine solution comprising up to about 0.2 mg/ml of norepinephrine concentration (as free base), a tonicity adjusting agent, at a pH where the norepinephrine is soluble which is packaged in a flexible plastic container, characterized by being storage stable for from about 12 months to about 24 months at room temperature of about 25° C.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: January 12, 2021
    Assignee: InfoRLife SA
    Inventors: Sergio Dusci, Sayan Dusci
  • STORAGE STABLE READY-TO-USE NOREPINEPHRINE AQUEOUS SOLUTIONS IN FLEXIBLE PLASTIC BAGS
    Publication number: 20200338020
    Abstract: A sterile, sulfite-free aqueous norepinephrine solution comprising up to about 0.2 mg/ml of norepinephrine concentration (as free base), a tonicity adjusting agent, at a pH where the norepinephrine is soluble which is packaged in a flexible plastic container, characterized by being storage stable for from about 12 months to about 24 months at room temperature of about 25° C.
    Type: Application
    Filed: April 26, 2019
    Publication date: October 29, 2020
    Applicant: InfoRLife SA
    Inventors: Sergio Dusci, Sayan Dusci
  • MIDAZOLAM IN FLEXIBLE BAGS
    Publication number: 20190388432
    Abstract: Terminally sterilized, preservative-free aqueous midazolam solution comprising 0.25 to 1.5 mg/ml of midazolam, a tonicity adjusting agent to provide an osmolality of from 260 and 320 mosm/kg and sufficient acid and optionally a base to provide a pH of from about 2.5 to 3.5 with the remainder water for injection packaged in a flexible plastic container.
    Type: Application
    Filed: June 20, 2018
    Publication date: December 26, 2019
    Applicant: InfoRLife SA
    Inventor: Sergio DUSCI